Restricted Sales and REMS Workflows

Introduction

Some medicines can't be handed over just because a customer asks and pays. For some, the law limits how much one person can buy. For others, specific steps must happen before the medicine leaves the pharmacy, such as checking ID, writing a record, or confirming that a patient is enrolled in a safety program.

This lesson covers two common examples. The first is the federal rules for cold and allergy products that contain pseudoephedrine. The second is the FDA safety programs called REMS. Both teach the same habit: getting the number right is only one check. A sale or fill can be correct in quantity and still not be allowed yet.

By the end of this lesson you should be able to:

• Use the federal daily limit (3.6 grams of base per purchaser per calendar day) and the 30-day purchase limit (9 grams of base) to decide whether a pseudoephedrine sale fits.
• Explain why the limit counts the base drug, not the number printed on the label, and read an equivalency table.
• Sort pseudoephedrine rules into quantity limits versus access, identity, recordkeeping and training controls.
• Explain why federal and state rules must both be followed.
• Explain what a REMS is and why its requirements must be met before dispensing.

What you need first: everyday arithmetic (adding, subtracting, multiplying, and changing milligrams to grams, where 1 g = 1,000 mg). It also helps to know how to find a product's active ingredient, which is covered in Read a medicine identity before learning a name.

Which products these sales rules cover

Pseudoephedrine is a decongestant found in prescription and over-the-counter (OTC) products used for nasal and sinus congestion. It can also be used illegally to make methamphetamine. To reduce that misuse, the federal Combat Methamphetamine Epidemic Act of 2005 (often shortened to CMEA, effective September 30, 2006) added sales controls.

The controls cover products containing any of three ingredients:

• pseudoephedrine
• ephedrine
• phenylpropanolamine

Federal rules call these scheduled listed chemical products. In plain terms, they are medicines containing one of these three chemicals, so their retail sale is regulated. The name sounds like the controlled-substance schedules taught in Controlled-substance schedules and valid orders, but this category has its own separate rules.

Combination products count. A multi-symptom cold product that contains pseudoephedrine is covered, even though it also contains other ingredients.

Read the active ingredient, not the brand. FDA's consumer guidance gave the example of Sudafed, which contains pseudoephedrine, and Sudafed PE, which contains phenylephrine. Phenylephrine is not one of the three chemicals these federal rules name. Similar brand names can hide different ingredients, so FDA tells consumers to read the label. This example teaches label reading. It does not say which products are currently sold.

The daily limit: 3.6 grams of base, per purchaser, per calendar day

The rule: A regulated seller, including a pharmacy, may not sell one purchaser more than 3.6 grams of pseudoephedrine base in a single calendar day. The same 3.6 g limit applies separately to ephedrine base and to phenylpropanolamine base.

Two phrases in the rule matter most.

"Without regard to the number of transactions." The limit covers the whole day for that purchaser, not each visit. A customer who buys some in the morning and returns in the afternoon is still under one daily total.

"Base." The limit counts the base, meaning the drug molecule itself. Medicines usually contain the drug as a salt, which is the drug bonded to a partner chemical so it can be made into a stable tablet. Pseudoephedrine hydrochloride (HCl) is one such salt.

The strength on the label, such as "60 mg pseudoephedrine HCl," is the weight of the whole salt. The base is only part of that weight. So you can't divide 3,600 mg by the label strength and get the right answer.

Use an equivalency table

DEA publishes a table showing how many tablets of each common product equal 3.6 g of base. Part of it:

Check that the table makes sense. 73 tablets × 60 mg = 4,380 mg of salt. That is more than 3,600 mg, yet the table allows it, because the 4,380 mg includes the HCl part. The tempting shortcut, 3,600 ÷ 60 = 60 tablets, gives the wrong limit because it treats salt weight as base weight.

Notice the two ephedrine rows. Both say "25 mg ephedrine," but the HCl salt allows 175 tablets and the sulfate salt allows 186. The same ingredient name doesn't mean the same product. The salt form changes how much base each tablet holds, so always match the exact salt and strength.

Worked example: one purchaser, two visits

Fictional assumptions: The product is 60 mg pseudoephedrine HCl tablets in boxes of 24. Nothing else containing pseudoephedrine is bought that day.

A customer buys 2 boxes in the morning and returns that afternoon asking for 2 more.

1. Find the daily maximum. The table says 73 tablets of 60 mg HCl.
2. Count everything sold to this purchaser today. Morning: 2 × 24 = 48 tablets.
3. Add the request. 48 + (2 × 24) = 96 tablets.
4. Compare. 96 is more than 73, so the request can't be filled as asked.
5. Find what still fits. 73 − 48 = 25 tablets remain. One more box (24 tablets) fits, for a day's total of 72. A second box would not fit.

The afternoon request alone (48 tablets) is under 73. That is the trap. The limit applies to the day's total for that purchaser, not to each transaction.

Changed case: only the strength changes

Now the same customer buys 120 mg pseudoephedrine HCl tablets in fictional boxes of 20, and this is their only purchase that day.

• The table maximum is 36 tablets.
• 1 box = 20 tablets, which fits.
• 2 boxes = 40 tablets, which exceeds 36.

Doubling the strength roughly halves the allowed count (73 becomes 36). The rule did not change. Only the base per tablet changed.

Question 1

Fictional assumptions: Product A boxes each contain 1.44 g of pseudoephedrine base. Product B boxes each contain 0.72 g of pseudoephedrine base. Earlier today, a purchaser bought 2 boxes of Product A. They now want 1 box of Product B. Then they ask whether they could take 2 boxes of B instead. Does either request fit the federal daily limit?

The 30-day purchase limit

The daily limit is not the only quantity rule.

• Daily limit (3.6 g base): The law tells the seller how much it may sell one purchaser per calendar day.
• 30-day limit (9 g base): The law makes it unlawful for a person to purchase more than 9 g of base at retail during a 30-day period. Of those 9 g, no more than 7.5 g may arrive by shipping (a private or commercial carrier, or the Postal Service).

The 7.5 g figure is part of the 9 g, not added to it. Separate rules also limit mail-order sellers and mobile retail vendors (such as sellers at flea markets) to 7.5 g per purchaser per 30 days. Don't add 7.5 and 9 together.

Worked example: each day passes, but the month doesn't

Fictional assumptions: All purchases below are pseudoephedrine, at a store counter, within one 30-day period.

On Day 15, the daily check alone says yes. The 30-day check says no. At most 9 − 7.2 = 1.8 g more fits in that period.

A sale must pass both checks. Passing one says nothing about the other.

Question 2

Fictional assumptions: Within the same 30-day period, a purchaser bought 2.4 g of pseudoephedrine base on the 1st and 3.6 g on the 12th. On the 20th they want 3.6 g. Which limit, if any, does the request break? What is the most that fits on the 20th?

Controls that are not quantity limits

Quantity limits answer how much. The other federal controls answer how the sale must happen. A sale can be within every limit and still be unlawful if these steps are skipped.

Access (where the product is kept and how it is handed over) - Behind-the-counter placement: customers must not have direct access to the product before the sale. A locked cabinet in a customer area also qualifies. Mobile retail vendors must use a locked cabinet. - The seller hands the product directly to the purchaser.

Identity (who is buying) - The purchaser presents a photo ID issued by a state or the federal government, or another identity document the federal rule accepts.

Recordkeeping (proof of the sale) - The logbook, written or electronic, records the product name, quantity sold, purchaser's name and address, and the date and time. - The purchaser signs the logbook. The seller enters the product and quantity. The seller also checks that the logged name matches the ID and that the date and time are correct. - The logbook displays a federal warning that falsifying entries is a crime. - Each entry is kept for at least 2 years and must be available for DEA inspection.

Training (who may handle the sale) - Staff who hand over these products or take payment for them must be trained. - The seller sends DEA a self-certification that the training happened and that it agrees to follow the rules. The seller keeps training records. - A separate certification is needed for each store location, and certifications are renewed annually after the first period. A seller may not sell these products without one.

Packaging - Solid forms (non-liquids) must come in blister packs holding no more than 2 dosage units per blister. If blister packs aren't technically feasible, unit-dose packets or pouches are used.

The small-package logbook exception and its limits

If an individual buys a single sales package containing not more than 60 mg of pseudoephedrine, federal law does not require a logbook entry for that purchase.

That exception is narrow:

• It removes the logbook requirement only.
• FDA states these packages must still stay behind the counter.
• The daily quantity limit applies to all of these products.
• The exception is written for one package of pseudoephedrine. Two such packages, or a larger package, are outside it.

Question 3

A customer wants one 2-tablet package containing 30 mg of pseudoephedrine in total. A new coworker says: "That's under 60 mg, so it's exempt. Put it on the open shelf by the register so customers can grab it." What is right and wrong in that statement?

Federal and state rules apply together

Many states have their own rules for these products. Some states require a prescription. Others set different limits or record rules. Federal law does not erase them, and they do not erase federal law.

• DEA's pharmacist manual states that sellers, including pharmacies, may not exceed the federal 3.6 g daily limit even if state law requires a prescription for the product.
• DEA's rules say that following them does not authorize anything state law forbids.
• FDA told consumers in states that already restricted these products that the federal law should not affect those state restrictions.

In practice: satisfy both sets of rules. If one is stricter on a point, meeting only the looser one isn't enough.

One helpful overlap: a record kept to satisfy state law can also satisfy the federal logbook rule, if it contains all the information the federal rule requires.

This lesson teaches federal rules. Your state's rules come from your state's law and board of pharmacy.

Question 4

Fictional assumption: A state requires a prescription for pseudoephedrine products. A customer presents a valid prescription for 60 mg pseudoephedrine HCl tablets with a quantity of 100 tablets, all to be dispensed today. Does the prescription allow all 100 tablets today under federal law?

REMS: required safety steps before dispensing

What a REMS is. A REMS (Risk Evaluation and Mitigation Strategy) is a safety program FDA requires for certain specific medicines that have a particular serious risk. It sets out what prescribers, pharmacies and patients must know or do to reduce that risk.

Each REMS is tailored to its medicine: its risks and the setting where it is used. That makes REMS product-specific. You can't assume that a different product, even one with the same ingredient or used for the same condition, has the same requirements. Check the program for the product you are actually filling.

What a REMS can include

Communication. Most REMS include information about the risk. A Medication Guide is an FDA-approved patient handout given with many prescriptions. Every Medication Guide is part of a drug's labeling, but only a small number are part of a REMS. Handing over a Medication Guide does not mean a REMS applies. And when a REMS has required steps, the handout alone does not satisfy them.

Required activities. Some REMS require steps called elements to assure safe use (ETASU): actions that must happen for the medicine to be used safely. In some cases, these must be done before the medicine can be prescribed, dispensed or received. Examples from FDA:

• The prescriber must be certified in the REMS.
• The pharmacy must be certified, which can mean training staff and setting up a process to verify the requirements.
• The patient must be enrolled.
• A safe-use condition must be documented before dispensing. One FDA example is a drug that can cause birth defects: a negative pregnancy test must be verified before it is dispensed to patients who could become pregnant.
• The medicine may be dispensed only in certain settings, such as one able to manage a particular adverse event on site.
• Patients may need monitoring or registry enrollment.

Each program's specific requirements are published on FDA's REMS@FDA website, and manufacturers often post REMS materials as well.

Why "before" matters

A REMS step done after the patient has the medicine can't prevent what it was designed to prevent. A pregnancy test checked next week does not protect against exposure today. That is why a pharmacy certified in a REMS may need to confirm that the prescriber is certified, the patient is enrolled, and the required lab result is documented before the medicine is dispensed.

Worked example: everything looks right except one thing

Fictional assumptions: "Drug Q" is an invented medicine. Its fictional REMS requires a certified prescriber, an enrolled patient, and a documented safe-use condition before each dispensing.

A prescription for Drug Q arrives. The directions are clear, the quantity math is correct, and insurance approved the claim. The REMS verification shows the patient is not enrolled.

• What the technician recognizes: a required REMS step is not complete.
• What happens next: the prescription is not dispensed. It goes to the pharmacist, following the pharmacy's REMS procedure.
• Why the other checks don't settle it: correct quantity and paid insurance answer different questions. Neither one is the safety step this REMS requires.

Changed case: the verification shows the prescriber is certified, the patient is enrolled, and the safe-use condition is documented. The REMS requirements are met, and the prescription continues through the pharmacy's normal process, including pharmacist verification.

The prescription and the math were the same in both cases. Only the REMS status changed, and that alone changed the outcome.

Who decides what. The technician's job is to recognize missing steps and stop the process. Clinical decisions belong to the pharmacist and prescriber. See Recognize when the pharmacist must intervene.

Question 5

A coworker says: "This medicine comes with a Medication Guide, so it must be a REMS drug. And once we hand the guide over, the REMS is done." What is wrong with each part?

Independent practice

Question 6

Fictional assumptions: Using the equivalency table above, a purchaser wants 30 mg pseudoephedrine HCl tablets in boxes of 48. They have bought no other products containing pseudoephedrine today. They ask for 4 boxes. How many full boxes can be sold today under the federal daily limit?

Question 7

Name the type of control each step represents: quantity limit, access, identity, recordkeeping or training.

1. Storing the product in a locked cabinet.
2. Checking that the name on a state photo ID matches the logbook.
3. Keeping a logbook entry for two years.
4. Refusing a sale that would bring the day's total to 4.0 g of base.
5. Sending DEA a self-certification that cashiers were trained.

Question 8

Fictional assumptions: A customer is within both the daily and 30-day limits, but they say they forgot their ID and offer to "just sign the book." The product requires a logbook entry. Can the sale proceed?

Question 9

Fictional assumptions: A prescription arrives for a medicine whose REMS requires the pharmacy to verify a documented safe-use condition before dispensing. The patient says they've taken it for a year, the line is long, and the pharmacist is on the phone. The record shows this month's required documentation is missing. What should the technician do, and why?

Question 10

A customer asks why they can't buy pseudoephedrine at a second store on the same day, since "each store is a separate sale." Using only the federal rules from this lesson, explain what applies and what doesn't.

What to remember

• Pseudoephedrine, ephedrine and phenylpropanolamine products, including combinations, have federal retail sales controls. Read the active ingredient, not the brand name.
• Daily limit: no more than 3.6 g of base sold to one purchaser per calendar day, counting every transaction that day. The limit counts base, not label (salt) strength, so use an equivalency table. For example, 60 mg pseudoephedrine HCl allows 73 tablets.
• 30-day limit: a person may not purchase more than 9 g of base in 30 days, and no more than 7.5 g of that may be shipped. A sale must pass the daily check and the 30-day check.
• Quantity is not the whole check. Access (behind the counter, handed directly to the purchaser), identity (photo ID), recordkeeping (signed logbook, kept 2 years), training (self-certification) and packaging rules apply too. The small-package exception (one package, 60 mg or less of pseudoephedrine) removes only the logbook entry.
• Federal and state rules both apply. Following one doesn't excuse breaking the other.
• A REMS is a product-specific FDA safety program. Some REMS require certification, enrollment or a documented safe-use condition before dispensing, because a step done afterward can't prevent the harm. Correct math, a valid prescription or a Medication Guide doesn't replace a missing REMS step. Recognize the gap, stop, and involve the pharmacist.

Review: A permitted quantity is only one condition

• The daily limit: 3.6 grams of base, per purchaser, per calendar day
• The 30-day purchase limit
• Controls that are not quantity limits